The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.
Soap Central on MSN6d
“Fork found in kitchen” — Netizens react to UnitedHealth reportedly overcharging cancer patients by 1000%UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was ...
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...
1. They came in prepared this time, with outrageous and lawless executive orders written and ready to roll out. 2. When Trump ...
The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...
Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback